Glucose counterregulation in diabetic autonomic neuropathy.
Webb
S M
SM
Fernández Castañer
M
M
D001342:Autonomic Nervous System Diseases / Q000503:physiopathology*; D001786:Blood Glucose / Q000378:metabolism*; D003929:Diabetic Neuropathies / Q000503:physiopathology*; D004837:Epinephrine / Q000097:blood; D005934:Glucagon / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced*; D007328:Insulin / Q000009:adverse effects; D007700:Kinetics; D009638:Norepinephrine / Q000097:blood; D010191:Pancreatic Polypeptide / Q000097:blood; D010275:Parasympathetic Nervous System / Q000503:physiopathology; D013004:Somatostatin / Q000097:blood; D013564:Sympathetic Nervous System / Q000503:physiopathology
D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin; D010191:Pancreatic Polypeptide; D013006:Growth Hormone; D005934:Glucagon; D006854:Hydrocortisone; D009638:Norepinephrine; D004837:Epinephrine